关于儿科软组织肉瘤的最新情况
Jamie Aye1,2, Jacquelyn Crane3,4, Sapna Oberoi5,6
1Children's of Alabama.
Current opinion in pediatrics
|December 26, 2025
概括
儿科软组织肉瘤 (STS) 的最新进展完善了风险分层,并确定了新的治疗点. 基因组洞察对于改善这些罕见的儿童癌症的结果至关重要.
科学领域:
- 儿科瘤学 儿科瘤学
- 癌症基因组学 癌症基因组学
- 肉瘤生物学的生物学
背景情况:
- 软组织瘤 (STS) 是一种罕见且多样化的儿科恶性瘤.
- 了解潜在的生物学是改善治疗结果的关键.
研究的目的:
- 审查近期诊断,生物学,风险分层和儿科STS治疗方面的进展.
- 突出基因组发现对临床管理的影响.
主要方法:
- 关于儿科软组织肉瘤的最新发现的文献综述.
- 预后因素和治疗点的分析,在rhabdomyosarcoma和其他STS亚型.
主要成果:
- FOXO1融合状态是拉布多米索尔科马 (RMS) 的关键预后因素.
- 在中等风险的RMS中,TP53和MYOD1突变以及循环瘤DNA影响存活率.
- 在RMS2005试验中,维持疗法改善了生存率.
- 针对性疗法如阿特佐利祖马布,拉罗特雷克提尼布和塔泽梅托斯塔特在特定的儿科STS亚型中显示出希望.
结论:
- 儿科STS在生物学上是异质的,需要量身定制的治疗方法.
- 基因组学的进步正在改善风险分层,并揭示新的治疗点.
- 国际合作和临床试验对于儿科STS治疗的未来进展至关重要.
相关概念视频
The Retinoblastoma Gene
4.6K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
Rous Sarcoma Virus (RSV) and Cancer
6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism
171
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
171
Pharmacokinetics in Pediatric Patients: Drug Distribution
234
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
234


